A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)

Condition:   Coronavirus Disease (COVID-19) Interventions:   Biological: V591;   Other: Placebo Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting

Source: ClinicalTrials.gov - August 4, 2020 Category: Research Source Type: clinical trials